ono 1078 has been researched along with Sleep Initiation and Maintenance Disorders in 2 studies
pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist
Sleep Initiation and Maintenance Disorders: Disorders characterized by impairment of the ability to initiate or maintain sleep. This may occur as a primary disorder or in association with another medical or psychiatric condition.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Montelukast 5mg and 10mg were non-inferior to pranlukast 450mg in the change from the baseline in the composite nasal symptoms scores." | 2.73 | A double-blind non-inferiority clinical study of montelukast, a cysteinyl leukotriene receptor 1 antagonist, compared with pranlukast in patients with seasonal allergic rhinitis. ( Baba, K; Okubo, K, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hara, H | 1 |
| Sugahara, K | 1 |
| Hashimoto, M | 1 |
| Mikuriya, T | 1 |
| Tahara, S | 1 |
| Yamashita, H | 1 |
| Okubo, K | 1 |
| Baba, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Mk0476 Phase II Dose Finding Study -Allergic Rhinitis-[NCT00446186] | Phase 2 | 945 participants (Actual) | Interventional | 2004-02-29 | Completed | ||
| MK0476 Phase III Double-Blind Comparative Study - Allergic Rhinitis[NCT00127647] | Phase 3 | 1,375 participants (Actual) | Interventional | 2004-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for ono 1078 and Sleep Initiation and Maintenance Disorders
| Article | Year |
|---|---|
A double-blind non-inferiority clinical study of montelukast, a cysteinyl leukotriene receptor 1 antagonist, compared with pranlukast in patients with seasonal allergic rhinitis.
Topics: Acetates; Adult; Chromones; Cyclopropanes; Double-Blind Method; Female; Humans; Leukotriene Antagoni | 2008 |
A double-blind non-inferiority clinical study of montelukast, a cysteinyl leukotriene receptor 1 antagonist, compared with pranlukast in patients with seasonal allergic rhinitis.
Topics: Acetates; Adult; Chromones; Cyclopropanes; Double-Blind Method; Female; Humans; Leukotriene Antagoni | 2008 |
A double-blind non-inferiority clinical study of montelukast, a cysteinyl leukotriene receptor 1 antagonist, compared with pranlukast in patients with seasonal allergic rhinitis.
Topics: Acetates; Adult; Chromones; Cyclopropanes; Double-Blind Method; Female; Humans; Leukotriene Antagoni | 2008 |
A double-blind non-inferiority clinical study of montelukast, a cysteinyl leukotriene receptor 1 antagonist, compared with pranlukast in patients with seasonal allergic rhinitis.
Topics: Acetates; Adult; Chromones; Cyclopropanes; Double-Blind Method; Female; Humans; Leukotriene Antagoni | 2008 |
1 other study available for ono 1078 and Sleep Initiation and Maintenance Disorders
| Article | Year |
|---|---|
Effectiveness of the leukotriene receptor antagonist pranlukast hydrate for the treatment of sleep disorder in patients with perennial allergic rhinitis.
Topics: Adult; Aged; Chromones; Female; Humans; Leukotriene Antagonists; Male; Middle Aged; Patient Satisfac | 2014 |